Pharmaceutical Lobbyists Fight Federal Oversight

| No Comments

Mass-scale pharmaceutical companies known as "compounders" are being taken to task at Congressional hearings Wednesday and Thursday pertaining to a recent outbreak of steroids tainted with deadly meningitis reports the New York Times.
The hearings are debating whether Congress will strengthen federal oversight of the pharmaceutical industry said the New York Times.
David Ball, a spokesman for lobbyist group the International Academy of Compounding Pharmacists, told the Boston Herald, "Compounders are regulated by states, and state governments are the entities that should govern and monitor the activities of all pharmacists."
The Boston Herald reports the patchwork security provided by state regulations of pharmaceutical companies was in part responsible for the Massachusetts breach that allowed a deadly batch of Meningitis-tainted steroids to be released throughout the nation last month.

Leave a comment

About this Entry

This page contains a single entry by Sara G published on November 15, 2012 1:04 PM.

Corcoran Update Met with Mixed Feelings was the previous entry in this blog.

Over the Counter Energy Shots Cited in Relation to 13 Deaths is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.